Literature DB >> 24324059

Soluble epoxide hydrolase deficiency inhibits dextran sulfate sodium-induced colitis and carcinogenesis in mice.

Wanying Zhang1, Haonan Li1, Hua Dong2, Jie Liao1, Bruce D Hammock2, Guang-Yu Yang1.   

Abstract

Soluble epoxide hydrolase (sEH) hydrolyses/inactivates anti-inflammatory epoxyeicosatrienoic acids (EETs) to their corresponding diols, and targeting sEH leads to strong anti-inflammatory effects. In the present study, using a tissue microarray and immunohistochemical approach, a significant increase of sEH expression was identified in ulcerative colitis (UC)-associated dysplasia and adenocarcinoma. The effects of deficiency in the sEH gene were determined on dextran sulfate sodium (DSS) colitis-induced carcinogenesis. The effects of EETs on lipopolysaccharide (LPS)-activated macrophages were analyzed in vitro. With extensive histopathological and immunohistochemical analyses, compared to wild-type mice, sEH(-/-) mice exhibited a significant decrease in tumor incidence (13/20 vs. 6/19, p<0.05) and a markedly reduced average tumor size (59.62±20.91 mm(3) vs. 22.42±11.22 mm(3)), and a significant number of pre-cancerous dysplasia (3±1.18 vs. 2±0.83, p<0.01). The inflammatory activity, as measured by the extent/proportion of erosion/ulceration/dense lymphoplasmacytosis (called active colitis index) in the colon, was significantly lower in sEH(-/-) mice (44.7%±24.9% vs. 20.2%±16.2%, p<0.01). The quantitative polymerase chain reaction (qPCR) assays demonstrated significantly low levels of cytokines/chemokines including monocyte chemoattractant protein (MCP-1), inducible nitric oxide synthase (iNOS), vasopressin-activated calcium-mobilizing (VCAM-1), interleukin-1 beta (IL-1β) and tumor necrosis factor-alpha (TNF-α). In vitro, LPS-activated macrophages treated with 14,15-EET showed a significant reduction of LPS-triggered IL-1β and TNF-α expression. Eicosanoic acid metabolic profiling revealed a significant increase of the ratios of EETs/ dihydroeicosatrienoic acids (DHETs) and epoxyoctadecennoic acid/dihydroxyoctadecenoic acid (EpOMEs/DiHOMEs). These results indicate that sEH plays an important role in the development of colitis and in inducing carcinogenesis.

Entities:  

Keywords:  Soluble epoxide hydrolase; carcinogenesis; colitis; dextran sulfate sodium; mice

Mesh:

Substances:

Year:  2013        PMID: 24324059      PMCID: PMC4076172     

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  40 in total

1.  Role of different inflammatory and tumor biomarkers in the development of ulcerative colitis-associated carcinogenesis.

Authors:  E Talero; S Sánchez-Fidalgo; I Villegas; C Alarcón de la Lastra; M Illanes; V Motilva
Journal:  Inflamm Bowel Dis       Date:  2010-08-18       Impact factor: 5.325

2.  Risk of colorectal cancer in patients with ulcerative colitis: a meta-analysis of population-based cohort studies.

Authors:  Tine Jess; Christine Rungoe; Laurent Peyrin-Biroulet
Journal:  Clin Gastroenterol Hepatol       Date:  2012-01-28       Impact factor: 11.382

3.  Inhibition of chronic ulcerative colitis associated adenocarcinoma development in mice by inositol compounds.

Authors:  Jie Liao; Darren N Seril; Allison L Yang; Gary G Lu; Guang-Yu Yang
Journal:  Carcinogenesis       Date:  2006-09-14       Impact factor: 4.944

4.  Enhancement of antinociception by coadministration of nonsteroidal anti-inflammatory drugs and soluble epoxide hydrolase inhibitors.

Authors:  Kara R Schmelzer; Bora Inceoglu; Lukas Kubala; In-Hae Kim; Steven L Jinks; Jason P Eiserich; Bruce D Hammock
Journal:  Proc Natl Acad Sci U S A       Date:  2006-09-01       Impact factor: 11.205

5.  Peptidyl-urea based inhibitors of soluble epoxide hydrolases.

Authors:  Christophe Morisseau; John W Newman; Hsing-Ju Tsai; Preston A Baecker; Bruce D Hammock
Journal:  Bioorg Med Chem Lett       Date:  2006-10-15       Impact factor: 2.823

6.  Compensatory mechanism for homeostatic blood pressure regulation in Ephx2 gene-disrupted mice.

Authors:  Ayala Luria; Steven M Weldon; Alisa K Kabcenell; Richard H Ingraham; Damian Matera; Huiping Jiang; Rajan Gill; Christophe Morisseau; John W Newman; Bruce D Hammock
Journal:  J Biol Chem       Date:  2006-11-29       Impact factor: 5.157

7.  Reduction of inflammatory bowel disease-induced tumor development in IL-10 knockout mice with soluble epoxide hydrolase gene deficiency.

Authors:  Wanying Zhang; Jie Liao; Haonan Li; Hua Dong; Han Bai; Allison Yang; Bruce D Hammock; Guang-Yu Yang
Journal:  Mol Carcinog       Date:  2012-04-19       Impact factor: 4.784

8.  Blocking TNF-alpha in mice reduces colorectal carcinogenesis associated with chronic colitis.

Authors:  Boryana K Popivanova; Kazuya Kitamura; Yu Wu; Toshikazu Kondo; Takashi Kagaya; Shiuchi Kaneko; Masanobu Oshima; Chifumi Fujii; Naofumi Mukaida
Journal:  J Clin Invest       Date:  2008-02       Impact factor: 14.808

9.  Severity of inflammation is a risk factor for colorectal neoplasia in ulcerative colitis.

Authors:  Matthew Rutter; Brian Saunders; Kay Wilkinson; Steve Rumbles; Gillian Schofield; Michael Kamm; Christopher Williams; Ashley Price; Ian Talbot; Alastair Forbes
Journal:  Gastroenterology       Date:  2004-02       Impact factor: 22.682

Review 10.  The Interleukin-23 / Interleukin-17 axis in intestinal inflammation.

Authors:  Kevin J Maloy
Journal:  J Intern Med       Date:  2008-06       Impact factor: 8.989

View more
  20 in total

1.  Inhibition of Chronic Pancreatitis and Murine Pancreatic Intraepithelial Neoplasia by a Dual Inhibitor of c-RAF and Soluble Epoxide Hydrolase in LSL-KrasG¹²D/Pdx-1-Cre Mice.

Authors:  Jie Liao; Sung Hee Hwang; Haonan Li; Jun-Yan Liu; Bruce D Hammock; Guang-Yu Yang
Journal:  Anticancer Res       Date:  2016-01       Impact factor: 2.480

Review 2.  Eicosanoid signaling in carcinogenesis of colorectal cancer.

Authors:  Yuxin Wang; Weicang Wang; Katherine Z Sanidad; Pei-An Shih; Xinfeng Zhao; Guodong Zhang
Journal:  Cancer Metastasis Rev       Date:  2018-09       Impact factor: 9.264

Review 3.  Epoxyeicosatrienoic acids, hypertension, and kidney injury.

Authors:  John D Imig
Journal:  Hypertension       Date:  2015-01-12       Impact factor: 10.190

4.  Anti-Ulcer Efficacy of Soluble Epoxide Hydrolase Inhibitor TPPU on Diclofenac-Induced Intestinal Ulcers.

Authors:  Sumanta Kumar Goswami; Debin Wan; Jun Yang; Carlos A Trindade da Silva; Christophe Morisseau; Sean D Kodani; Guang-Yu Yang; Bora Inceoglu; Bruce D Hammock
Journal:  J Pharmacol Exp Ther       Date:  2016-03-17       Impact factor: 4.030

Review 5.  Soluble epoxide hydrolase as a therapeutic target for obesity-induced disorders: roles of gut barrier function involved.

Authors:  Jianan Zhang; Maolin Tu; Zhenhua Liu; Guodong Zhang
Journal:  Prostaglandins Leukot Essent Fatty Acids       Date:  2020-09-19       Impact factor: 4.006

Review 6.  Role of linoleic acid-derived oxylipins in cancer.

Authors:  Matthew L Edin; Caroline Duval; Guodong Zhang; Darryl C Zeldin
Journal:  Cancer Metastasis Rev       Date:  2020-09       Impact factor: 9.264

7.  Inhibition of soluble epoxide hydrolase attenuates eosinophil recruitment and food allergen-induced gastrointestinal inflammation.

Authors:  Idil Bastan; Xiao Na Ge; Mythili Dileepan; Yana G Greenberg; Alonso G Guedes; Sung Hee Hwang; Bruce D Hammock; Robert J Washabau; Savita P Rao; P Sriramarao
Journal:  J Leukoc Biol       Date:  2018-01-17       Impact factor: 4.962

Review 8.  Prospective for cytochrome P450 epoxygenase cardiovascular and renal therapeutics.

Authors:  John D Imig
Journal:  Pharmacol Ther       Date:  2018-06-30       Impact factor: 12.310

Review 9.  Targeting the eicosanoid pathway in hepatocellular carcinoma.

Authors:  Anshuli Razdan; Nathan M Main; Vincent Chiu; Nicholas A Shackel; Paul de Souza; Katherine Bryant; Kieran F Scott
Journal:  Am J Cancer Res       Date:  2021-06-15       Impact factor: 6.166

10.  Lipidomic profiling reveals soluble epoxide hydrolase as a therapeutic target of obesity-induced colonic inflammation.

Authors:  Weicang Wang; Jun Yang; Jianan Zhang; Yuxin Wang; Sung Hee Hwang; Weipeng Qi; Debin Wan; Daeyoung Kim; Jia Sun; Katherine Z Sanidad; Haixia Yang; Yeonhwa Park; Jun-Yan Liu; Xinfeng Zhao; Xiaohui Zheng; Zhenhua Liu; Bruce D Hammock; Guodong Zhang
Journal:  Proc Natl Acad Sci U S A       Date:  2018-05-01       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.